Ticagrelor: a novel antiplatelet agent for patients with acute coronary syndrome

Hinneburg, I.

Medizinische Monatsschrift für Pharmazeuten 34(7): 226-232

2011


ISSN/ISBN: 0342-9601
PMID: 21809597
Document Number: 649202
Ticagrelor is an oral, reversible blocker of the P2Y12 adenosine receptor. In clinical trials the antiplatelet agent reduced significantly vascular mortality and death from any cause when compared to clopidogrel in patients with acute coronary syndrome.

Document emailed within 1 workday
Secure & encrypted payments